Cite
HARVARD Citation
Lim, S. et al. (2022). Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects. Diabetes, obesity & metabolism. 24 (4), pp. 757-762. [Online].